Pegus Research Enters a Multi-Year Enterprise Agreement with DATATRAK
Recognizing the benefits of the UNIFIED EXPERIENCE™
PR Newswire
CLEVELAND, July 21, 2014
CLEVELAND , July 21, 2014 /PRNewswire/ – D ATATRAK International, Inc. (OTCQX: DTRK), the leader in developing cloud-based, unified eClinical ® technologies and delivering related services for the clinical trials industry, today announced Pegus Research has entered a multi-year Enterprise Agreement for D ATATRAK solutions and services .
"We are proud to count Pegus among our D ATATRAK partners," said Laurence P. Birch , Chairman and CEO, D ATATRAK . "They have seen, first hand, the safe acceleration of trials with the DATATRAK ONE ® Unified Experience ™ solutions , " said Birch. "The move from trial-by-trial use to an Enterprise Agreement provides additional advantages, including removing the constraints of repetitive contracting, establishing long-term consistent pricing, enhancing access to D ATATRAK technology and services, and creating a central library for standardized eCRF usage across all of their sponsor trials," concluded Birch.
The Unified Experience ™ triggers advantages to each solution of the Unified Platform, with increased benefits realized from increased product usage.
| UX CTMS ™ | Plan and Manage Your Trial |
| UX Trial Design ™ | Design-to-Deployment in One Tool |
| UX EDC & Medical Coding ™ | Capture and Deliver Your Data |
| UX Randomization & Trial Supply | |
| Management ™ (UX RTMS ™ ) | Randomize Patients & Automate Supply |
| UX Patient Data Capture ™ | Collect Patient Driven Data |
| UX Safety ™ | Manage Individual Case Safety Reports |
| UX Training ™ | Train Users and Track Certificates |
"PEGUS Research is pleased for the opportunity to partner with D ATATRAK to deliver the most efficient and flexible EDC architecture possible to our pharmaceutical clients and sites. With enhanced features like question visibility logic, the DATATRAK ONE ® Unified Platform has proven to be the most robust and advanced solution for meeting the unique design requirements of all the EDC studies PEGUS conducts," said Clark Richardson , President of PEGUS Research.
The DATATRAK ONE ® Unified Experience ™ removes clinical research complexities, accelerating the ultimate outcome of every trial. The strength of D ATATRAK eClinical solutions is the intrinsic connection to the DATATRAK ONE ® Unified Platform, with all products powered by a single data source providing exceptional system reliability, eliminating the need for integration and minimizing downtime, enabling agile mid-study changes, delivered through an easy-to-use interface. Powered by the Cloud, the DATATRAK ONE ® Unified Experience ™ solutions result in better site compliance, better data, and ultimately a safer trial
Join D ATATRAK Thought Leaders:
Tweet: .@PEGUSresearch & DATATRAK Enterprise Agreement Confirmed Upgrading trial by trial partnership #eClinical http://bit.ly/1mZWz9n
About D ATATRAK International, Inc.
D ATATRAK International is a worldwide technology and services company delivering unified eClinical ® solutions and related services for the clinical trials industry. D ATATRAK built its multi-component, comprehensive solution on a single, unified platform and expanded this concept to include services delivery via the D ATATRAK Clinical and Consulting Services group. The Company delivers a complete portfolio of software products designed to accelerate the reporting of clinical research data from sites to sponsors and ultimately regulatory authorities, faster and more efficiently than loosely integrated technologies. The DATATRAK ONE ® software solution, deployed worldwide through an ASP or Enterprise Transfer offering, supports Preclinical and Phase I - Phase IV drug and device studies in multiple languages throughout the world. D ATATRAK is located in Cleveland, Ohio ; Bryan, Texas ; Cary (RTP), North Carolina , and the UK. For more information, visit http://www.datatrak.com .
Except for the historical information contained in this press release, the statements made in this release are forward-looking statements. These forward-looking statements
are made based on management's expectations, assumptions, estimates and current beliefs concerning the operations, future results and prospects of the Company and are subject to uncertainties and factors which are difficult to predict and, in many instances, are beyond the control of the Company, and which could cause actual results to differ materially from those contemplated in these forward-looking statements. For a list of certain factors that may cause actual results to differ materially from those contemplated in these forward looking statements, please see the Company's report filed with the OTCQX Market on May 14, 2014 announcing its results for the first quarter period ending March 31, 2014 . The Company undertakes no obligation to update publicly or revise any forward-looking statement whether as a result of new information, future events or otherwise.
SOURCE DATATRAK International, Inc.
